110例BI-RADS 4C与5类不可触及乳腺良性病变的超声、细胞学与组织学特征相关性
研究回顾2003至2007年间849例超声检出并分类为BI-RADS 4C(505例)或5类(344例)的不可触及乳腺病变,其中110例(12.9%)最终为良性。良性病变涵盖上皮与纤维增生、囊性与乳头状病变等多种病理类型,各类型超声表现存在显著差异;细针穿刺(FNA)诊断良性者90例(82%)。
要点
- BI-RADS 4C或5类不可触及乳腺病变中12.9%为良性,病理类型多样。
- 良性病变各病理类型的形态、超声模式和后方特征分布存在显著差异。
- FNA对良性病变的诊断中82%为良性,但仍有假阳性与可疑结果。
核心结论
- 超声分类为BI-RADS 4C或5类的不可触及乳腺病变中,良性者病理类型多样且各有特定影像表现。
研究设计与样本
- 回顾性研究,2003至2007年849例超声检出并分类为BI-RADS 4C(505例)或5类(344例)的不可触及乳腺病变,均先行超声引导下FNA。
- 良性诊断依据手术切除结果或至少6个月影像随访(平均3.7年,标准差2.6年)确定。
- 采用卡方检验回顾性比较各病理类别的超声BI-RADS特征,并评估FNA诊断良性病变的表现。
主要发现
- 849例中110例(12.9%)为良性,其中BI-RADS 4C类88例(17.4%)、5类22例(6.4%)。
- 良性病变中上皮与纤维增生44例(40%)、囊性与乳头状病变21例(19%)、非特异性形态改变13例(12%)、炎症性病变11例(10%)、良性肿瘤11例(10%)、上皮内增生性病变8例(7%)、乳腺内淋巴结2例(2%)。
- 病变形状、超声模式分布和后方特征在各病理类别间差异有统计学意义(P < .05)。
- 33例(75%)上皮与纤维增生表现为后方声影,18例(86%)囊性与乳头状病变为均匀,9例(82%)炎症性病变为不均匀,11例(100%)良性肿瘤为均匀,9例(82%)良性肿瘤为椭圆形,6例(75%)上皮内增生性病变形状不规则。
- 110例良性病变中FNA诊断假阳性7例(6%)、可疑10例(9%)、良性90例(82%)、取材不足3例(3%)。
关键数值与推荐
- BI-RADS 4C或5类不可触及乳腺病变中良性占12.9%(110/849)。
- FNA诊断良性者为82%(90/110),假阳性6%(7/110),可疑9%(10/110),取材不足3%(3/110)。
临床怎么用
- 对超声分类为BI-RADS 4C或5类的不可触及乳腺病变,应认识其良性病理类型多样及各自影像表现,结合FNA结果综合判断。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The purpose of this study was to determine the pathological and ultrasound (US) features of benign nonpalpable breast lesions (NPBLs) classified as Breast Imaging Reporting and Data System (BI-RADS) category 4C or 5. METHODS: Between 2003 and 2007, 849 consecutive NPBLs detected at US and classified as BI-RADS category 4C (505) or 5 (344) initially underwent US-guided fine needle aspiration (FNA) at our institution. Benign diagnoses were established according to surgical excision findings or during a minimal 6-month imaging follow-up (mean, 3.7 years [SD, 2.6 years]). US BI-RADS features were reviewed and compared retrospectively using a chi-square test for the following pathological categories: epithelial and fibrous proliferation (EFP), cystic and papillary lesion (C&P), inflammatory lesion (IL), benign tumor (BT), intramammary lymph node (ILN), intraepithelial proliferative lesion (IPL), and nonspecific morphological alteration (NMA). The performance of FNA in the diagnosis of benignity was assessed. RESULTS: Of 849 NPBLs, 110 (12.9%) NPBLs were benign: 88 (17.4%) were BI-RADS category 4C, and 22 (6.4%) were BI-RADS category 5. Forty-four (40%) were EFPs, 21 (19%) were C&Ps, 13 (12%) were NMAs, 11 (10%) were ILs, 11 (10%) were BTs, 8 (7%) were IPLs, and 2 (2%) were ILNs. Lesion shape, US pattern distribution, and posterior features showed statistically significant differences between these categories (P < .05): 33 (75%) EFPs exhibited posterior shadowing, 18 (86%) C&Ps were homogenous, 9 (82%) ILs were heterogeneous, 11 (100%) BTs were homogeneous, 9 (82%) BTs were oval, and 6 (75%) IPLs were irregularly shaped. Of the 110 benign NPBLs, FNA diagnosis was falsely positive in 7 (6%), suspicious in 10 (9%), and benign in 90 (82%), and 3 (3%) were inadequate for diagnosis. CONCLUSION: A diverse array of benign NPBLs can be classified as BI-RADS category 4C or 5 on US, each showing specific imaging presentations.
引用
- Farras Roca JA, Tardivon A, Thibault F, et al. Correlation of ultrasound, cytological, and histological features of 110 benign BI-RADS categories 4C and 5 nonpalpable breast lesions. The Institut Curie's experience. Cancer Cytopathol. 2021. PMID: 33689204. doi:10.1002/cncy.22402
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。